172 related articles for article (PubMed ID: 35447036)
1. Characteristics and Management of Granulomatous Lobular Mastitis Associated with Antipsychotics-Induced Hyperprolactinemia.
Tian C; Wang H; Liu Z; Han X; Ning P
Breastfeed Med; 2022 Jul; 17(7):599-604. PubMed ID: 35447036
[No Abstract] [Full Text] [Related]
2. Hyperprolactinemia in psychotic patients treated in monotherapy with long-acting injectable antipsychotics.
Bonete Llácer JM; Martínez Hortelano A; Richart Albelda B
Int J Psychiatry Clin Pract; 2019 Sep; 23(3):189-193. PubMed ID: 30848967
[No Abstract] [Full Text] [Related]
3. The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.
Peuskens J; Pani L; Detraux J; De Hert M
CNS Drugs; 2014 May; 28(5):421-53. PubMed ID: 24677189
[TBL] [Abstract][Full Text] [Related]
4. Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics.
Chen CK; Huang YS; Ree SC; Hsiao CC
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1495-9. PubMed ID: 20732372
[TBL] [Abstract][Full Text] [Related]
5. Association between Hyperprolactinemia and Granulomatous Mastitis.
Nikolaev A; Blake CN; Carlson DL
Breast J; 2016; 22(2):224-31. PubMed ID: 26705962
[TBL] [Abstract][Full Text] [Related]
6. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
Lu ML; Shen WW; Chen CH
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic granulomatous mastitis associated with risperidone-induced hyperprolactinemia.
Lin CH; Hsu CW; Tsao TY; Chou J
Diagn Pathol; 2012 Jan; 7():2. PubMed ID: 22221904
[TBL] [Abstract][Full Text] [Related]
8. [Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].
Haefliger T; Bonsack C
Encephale; 2006; 32(1 Pt 1):97-105. PubMed ID: 16633296
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
Chen JX; Su YA; Bian QT; Wei LH; Zhang RZ; Liu YH; Correll C; Soares JC; Yang FD; Wang SL; Zhang XY
Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348
[TBL] [Abstract][Full Text] [Related]
10. Effect of antipsychotic-induced hyperprolactinemia on anthropometric measures, insulin sensitivity and lipid profile in patients with schizophrenia or related psychoses.
Melkersson K; Berinder K; Hulting AL
Neuro Endocrinol Lett; 2011; 32(4):428-36. PubMed ID: 21876517
[TBL] [Abstract][Full Text] [Related]
11. Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders.
Tollin SR
J Endocrinol Invest; 2000 Dec; 23(11):765-70. PubMed ID: 11194712
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.
Kinon BJ; Gilmore JA; Liu H; Halbreich UM
Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():55-68. PubMed ID: 12650681
[TBL] [Abstract][Full Text] [Related]
13. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotics-induced hyperprolactinemia and screening for macroprolactin.
Ruljancic N; Bakliza A; Vuk Pisk S; Geres N; Matic K; Ivezic E; Grosic V; Filipcic I
Biochem Med (Zagreb); 2021 Feb; 31(1):010707. PubMed ID: 33380894
[TBL] [Abstract][Full Text] [Related]
15. Psychiatric Patients with Antipsychotic Drug-Induced Hyperprolactinemia and Menstruation Disorders.
Takechi K; Yoshioka Y; Kawazoe H; Tanaka M; Takatori S; Kobayashi M; Matsuoka I; Yanagawa H; Zamami Y; Imanishi M; Ishizawa K; Tanaka A; Araki H
Biol Pharm Bull; 2017; 40(10):1775-1778. PubMed ID: 28966250
[TBL] [Abstract][Full Text] [Related]
16. Hyperprolactinemia and Antipsychotic Therapy in Schizophrenic Patients with Hashimoto's Thyroiditis.
Sobolevskaia PA; Churilov LP; Fedotkina TV; Stepochkina A; Dolina A; Gvozdetckii AN; Andreev BV; Shoenfeld Y
Psychiatr Danub; 2021; 33(Suppl 4):1106-1112. PubMed ID: 35354176
[TBL] [Abstract][Full Text] [Related]
17. Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study.
Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC
Psychopharmacology (Berl); 2005 Feb; 178(1):35-40. PubMed ID: 15289996
[TBL] [Abstract][Full Text] [Related]
18. Differences in prolactin elevation and related symptoms of atypical antipsychotics in schizophrenic patients.
Melkersson K
J Clin Psychiatry; 2005 Jun; 66(6):761-7. PubMed ID: 15960571
[TBL] [Abstract][Full Text] [Related]
19. Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review.
De Hert M; Detraux J; Stubbs B
Expert Opin Drug Saf; 2016 Jun; 15(6):809-23. PubMed ID: 26986209
[TBL] [Abstract][Full Text] [Related]
20. Idiopathic granulomatous mastitis associated with hyperprolactinemia: A nonoperative approach.
Li J; McGregor HP
Breast J; 2017 Nov; 23(6):742-744. PubMed ID: 28845595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]